
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer
Anup Biswas, Seo-Young Han, Yifan Tai, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 1002-1021
Open Access | Times Cited: 43
Anup Biswas, Seo-Young Han, Yifan Tai, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 1002-1021
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
Zhilei Zhang, Yonghua Wang, Zhijuan Liang, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108142-108142
Open Access | Times Cited: 5
Zhilei Zhang, Yonghua Wang, Zhijuan Liang, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108142-108142
Open Access | Times Cited: 5
ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis
Jingjing Zhang, Lingjie Li, Weiwei Luo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 12, pp. 2979-2992
Closed Access | Times Cited: 1
Jingjing Zhang, Lingjie Li, Weiwei Luo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 12, pp. 2979-2992
Closed Access | Times Cited: 1
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer
Yifan Tai, Angela Chow, Seo-Young Han, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 8, pp. 1957-1980
Open Access | Times Cited: 1
Yifan Tai, Angela Chow, Seo-Young Han, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 8, pp. 1957-1980
Open Access | Times Cited: 1
Regulation of metastatic organotropism
Karen J. Dunbar, Gizem Efe, Katherine Cunningham, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 1
Karen J. Dunbar, Gizem Efe, Katherine Cunningham, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 1
From targeted therapy to a novel way: Immunogenic cell death in lung cancer
Jiawei Xu, Yiyi Xiong, Zhou Xu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Jiawei Xu, Yiyi Xiong, Zhou Xu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells
G. E. Brown
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4814-4814
Open Access | Times Cited: 7
G. E. Brown
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4814-4814
Open Access | Times Cited: 7
Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study
Ying Du, Henan Xin, Xuefang Cao, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Ying Du, Henan Xin, Xuefang Cao, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer
Chao Guan, Xiaoye Zhang, Li Yu
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 5, pp. 627-637
Closed Access | Times Cited: 2
Chao Guan, Xiaoye Zhang, Li Yu
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 5, pp. 627-637
Closed Access | Times Cited: 2
MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going
Roberto Cuttano, Miriam Kuku Afanga, Fabrizio Bianchi
Cancers (2022) Vol. 14, Iss. 23, pp. 5731-5731
Open Access | Times Cited: 4
Roberto Cuttano, Miriam Kuku Afanga, Fabrizio Bianchi
Cancers (2022) Vol. 14, Iss. 23, pp. 5731-5731
Open Access | Times Cited: 4
From pre-clinical to translational brain metastasis research: current challenges and emerging opportunities
Emilija Aleksandrovic, Siyuan Zhang, Dihua Yu
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 3, pp. 187-198
Open Access
Emilija Aleksandrovic, Siyuan Zhang, Dihua Yu
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 3, pp. 187-198
Open Access
Single-cell atlas reveals the immunosuppressive microenvironment and Treg cells landscapes in recurrent Glioblastoma
Xingdong Wang, Yizhi Ge, Yuting Hou, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 790-801
Closed Access
Xingdong Wang, Yizhi Ge, Yuting Hou, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 790-801
Closed Access
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status
Jun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 424-438
Open Access
Jun Zhang, Lanlan Zhou, Shuai Zhao, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 424-438
Open Access
Alarming and Calming: dual functions of S100A9 on Mycoplasma gallisepticun infection in avian cells
Yingjie Wang, Mengyun Zou, Jin Liu, et al.
Veterinary Microbiology (2024) Vol. 296, pp. 110175-110175
Closed Access
Yingjie Wang, Mengyun Zou, Jin Liu, et al.
Veterinary Microbiology (2024) Vol. 296, pp. 110175-110175
Closed Access
Metastatic brain tumors: from development to cutting‐edge treatment
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access
The Significance of Aldehyde Dehydrogenase 1 in Cancers
A. Nguyen, Caroline O. Facey, Bruce M. Boman
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 251-251
Open Access
A. Nguyen, Caroline O. Facey, Bruce M. Boman
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 251-251
Open Access
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling
Valerio Ciccone, Vittoria Simonis, Cinzia Del Gaudio, et al.
Research Square (Research Square) (2023)
Open Access
Valerio Ciccone, Vittoria Simonis, Cinzia Del Gaudio, et al.
Research Square (Research Square) (2023)
Open Access
[SWI/SNF Complex Gene Mutations Promote the Liver Metastasis
of Non-small Cell Lung Cancer Cells in NSI Mice].
Lingling Gao, Zhi Xie, Shouheng Lin, et al.
PubMed (2023) Vol. 26, Iss. 10, pp. 753-764
Closed Access
Lingling Gao, Zhi Xie, Shouheng Lin, et al.
PubMed (2023) Vol. 26, Iss. 10, pp. 753-764
Closed Access
Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
Keigo Kobayashi
Journal of Respiration (2023) Vol. 3, Iss. 4, pp. 223-236
Open Access
Keigo Kobayashi
Journal of Respiration (2023) Vol. 3, Iss. 4, pp. 223-236
Open Access